UPDF AI

Targets for Medical Therapy in Obesity

M. Baretić

2012 · DOI: 10.1159/000336672
Digestive Diseases · 29 Citações

TLDR

The anti-obesity drug should target patients that have previously failed to lose weight with lifestyle interventions, with body mass index (BMI) ≥30, or those with BMI ≥27 plus concomitant obesity-related risk factors or diseases.